The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Veronneau Marcel since 2008.
The trader's CIK number is 1213074.
At the time of the last reporting, Veronneau Marcel was the VP-Hematology Operat of Bio-techne Corp. (stock ticker symbol TECH).
Also see all insider trading activities at Bio-techne Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | TECH | 0 | $0 | 0 | $0 | 385 | $30,572 |
| 2014 | TECH | 0 | $0 | 0 | $0 | 510 | $28,983 |
| 2013 | TECH | 0 | $0 | 0 | $0 | 567 | $28,026 |
| 2012 | TECH | 0 | $0 | 475 | $32,095 | 475 | $24,510 |
| 2011 | TECH | 0 | $0 | 505 | $41,003 | 505 | $20,437 |
| 2010 | TECH | 0 | $0 | 7,511 | $458,771 | 15,670 | $577,843 |
| 2009 | TECH | 0 | $0 | 0 | $0 | 785 | $22,152 |
| 2008 | TECH | 0 | $0 | 0 | $0 | 748 | $24,310 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-08 | TECH | Option Ex | 385 | 79.41 | 30,572 |
| 2014-06-02 | TECH | Option Ex | 510 | 56.83 | 28,983 |
| 2013-07-01 | TECH | Option Ex | 567 | 49.43 | 28,026 |
| 2012-08-14 | TECH | Option Ex | 475 | 51.60 | 24,510 |
| 2012-08-14 | TECH | Sale | 475 | 67.57 | 32,095 |
| 2011-05-26 | TECH | Option Ex | 505 | 40.47 | 20,437 |
| 2011-05-26 | TECH | Sale | 505 | 81.20 | 41,003 |
| 2010-11-02 | TECH | Option Ex | 7,489 | 37.01 | 277,175 |
| 2010-11-03 | TECH | Option Ex | 7,511 | 37.01 | 277,989 |
| 2010-11-03 | TECH | Sale | 7,511 | 61.08 | 458,771 |
| 2010-08-04 | TECH | Option Ex | 670 | 33.85 | 22,679 |
| 2009-06-05 | TECH | Option Ex | 785 | 28.22 | 22,152 |
| 2008-05-08 | TECH | Option Ex | 748 | 32.50 | 24,310 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Veronneau Marcel (VP-Hematology Operat of Bio-techne Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.